Home/Filings/4/0000899243-21-036424
4//SEC Filing

CHEN ISAN 4

Accession 0000899243-21-036424

CIK 0001863127other

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 4:42 PM ET

Size

9.3 KB

Accession

0000899243-21-036424

Insider Transaction Report

Form 4
Period: 2021-09-17
CHEN ISAN
Director
Transactions
  • Conversion

    Series A Preferred Stock

    2021-09-1716,3660 total
    Common Stock (42,509 underlying)
  • Conversion

    Common Stock

    2021-09-17+61,444192,783 total
  • Conversion

    Series B Preferred Stock

    2021-09-177,2900 total
    Common Stock (18,935 underlying)
Footnotes (2)
  • [F1]On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F2]Includes 37,105 shares subject to repurchase by us, which are subject to vesting.

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001586218

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 4:42 PM ET
Size
9.3 KB